← Evidence map

ReviewJournal of cancer research and clinical oncology2021

Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy.

Yuxin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34661758